glp 1/gip receptor agonist Dual GIP/GLP-1 agonists: New advances for treating type-2 diabetes Targeting GLP-1, GIP & GCG

Description

Novo Nordisk is seeking to replace the existing glucagon-like peptide-1 (GLP-1) receptor agonist (RA) with a second-generation drug, semaglutide, to fight diabetes and obesity in Korea.On Thursday, the Ministry of Food and Drug Safety authorized the use of Novo Nordisks Ozempic to treat adults with

Therefore, further research is necessary to fully understand the potential of GLP-1 receptor agonists in providing comprehensive protection against complications related to T2DM.

Eli Lillys first nine months of 2025 underscored the scale of the GLP-1 surge: Mounjaro and Zepbound generated $39.5 billion in revenue and surpasses Mercks Keytruda as the worlds best-selling medicine[5]

GLP-1 agonists may lessen alcohol, smoking and possibly drug addictions

Plant-Based Insulin Modulation Ceylon Cinnamon and Berberine help maintain a balanced response to glucose intake, supporting steady energy levels throughout the day.